Overview

Pharmacokinetics, Safety, Tolerability and Pharmacodynamics of BMS-986189 in Healthy Subjects

Status:
Completed
Trial end date:
2016-12-14
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to measure the amount of study drug (BMS-986189) in the blood and urine and to see if BMS-986189 is safe and well-tolerated in healthy people after a single dose.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb